BackScience Strategic Acquisition Alpha - Warrants (20/01/2026) Overview
Science Strategic Acquisition Corp Alpha - Warrants (20/01/2026)

Science Strategic Acquisition Alpha - Warrants (20/01/2026) Return on Equity

Science Strategic Acquisition Alpha - Warrants (20/01/2026) (SSAAW) has a ROE of -64329.85%, below the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

-64329.85%

Return on Equity

-64329.85%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Science Strategic Acquisition Alpha - Warrants (20/01/2026) (SSAAW) FAQ

The latest ROE for SSAAW is -64329.85%. That is below the sector sector average of 11.85%. Investors often review this figure alongside Science Strategic Acquisition Alpha - Warrants (20/01/2026)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SSAAW currently prints -64329.85% for ROE, while the sector average sits near 11.85%. That is roughly 542867.4% below the sector mean. Large gaps often invite a closer look at Science Strategic Acquisition Alpha - Warrants (20/01/2026)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Science Strategic Acquisition Alpha - Warrants (20/01/2026) converts resources into returns. At -64329.85%, SSAAW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SSAAW's ROE (-64329.85%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.